Nerve stimulation shows promise as prophylactic:
This article was originally published in Clinica
Executive Summary
Preclinical studies of vagus nerve stimulation have shown that the technique could slow, or even stop, the progress of epilepsy. Experiments on cats, by researchers at the Instituto Mexicano de Psiquiarria in Mexico City, indicated that animals with electrically-induced epilepsy could have the development of their seizures delayed with a series of four one-minute treatments (Epilepsia, July). The researchers, who used Houston, Texas-based Cyberonics' device, concluded that research should now be carried out on humans. The technique is already used for refractory seizures.
You may also be interested in...
US Q1 Consumer Health Earnings Preview: Label This One Historic And Challenging But Promising
US OTC drug and supplement firms’ reports of results for the first three months of 2024 began on April 19 with P&G. JP Morgan analysts say while “some retailers in the US in particular” are reducing consumer health inventories, for the overall sector they expect “a healthier balance of positive volume and lower pricing contribution.”
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.
Partisan Politics Returns To US FDA Congressional Oversight
The US FDA has stood out as an agency that tends to draw broad bipartisan support amid a generally rancorous and divided Congress. A House hearing, however, may be a sign that those days are over.